Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Heart Transplantation

  Free Subscription


01.06.2020

1 Ann Thorac Surg
4 Clin Transplant
317 J Heart Lung Transplant
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Thorac Surg

  1. LI Q, Hara H, Banks CA, Yamamoto T, et al
    Anti-Pig Antibody in Infants: Can a Genetically Engineered Pig Heart Bridge to Allotransplantation?
    Ann Thorac Surg. 2020;109:1268-1273.
    PubMed         Abstract available


    Clin Transplant

  2. DOMINGUEZ JM, Garcia-Romero E, Pamies J, Mirabet S, et al
    Incidence of Vasoplegic Syndrome After Cardiac Transplantation in Patients Treated with Sacubitril/Valsartan.
    Clin Transplant. 2020 May 28:e13994. doi: 10.1111/ctr.13994.
    PubMed         Abstract available

  3. BROCH K, Gude E, Karason K, Dellgren G, et al
    Cholesterol-lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trial.
    Clin Transplant. 2020 May 23:e13984. doi: 10.1111/ctr.13984.
    PubMed         Abstract available

  4. TADROS HJ, Lopez-Colon D, Bleiweis MS, Fricker FJ, et al
    Post-operative vasoactive inotropic score is predictive of outcomes in pediatric heart transplantation.
    Clin Transplant. 2020 May 22:e13986. doi: 10.1111/ctr.13986.
    PubMed         Abstract available

  5. REYENTOVICH A, Gidea CG, Smith D, Lonze B, et al
    Outcomes with Treatment with Glecaprevir/Pibrentasvir Following Heart Transplantation Utilizing Hepatitis C Viremic Donors.
    Clin Transplant. 2020 May 22:e13989. doi: 10.1111/ctr.13989.
    PubMed         Abstract available


    J Heart Lung Transplant

  6. PINSINO A, Jennings DL, Mahoney I, Sweat A, et al
    Serum Cystatin C versus Creatinine Based Assessment of Renal Function in Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  7. GUPTA R, Punnoose LR, Marvin-Peek J, Schlendorf KH, et al
    Trends in Blood Urea Nitrogen to Creatinine Ratio between Listing and Heart Transplant are Associated with Poor Post-Transplant Outcomes.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  8. GUPTA R, Schlendorf KH, Shah A, Punnoose LR, et al
    Trends in MELD-XI between Listing and Transplant are Associated with Poor Outcomes in Heart Transplant Recipients with Stage 3 Chronic Kidney Disease.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  9. KODEBOINA M, Verstreken S, Goethals M, Dierckx R, et al
    Hemodynamic Response to Acute Volume Load in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  10. KIM D, Choi J, Cho H, Jung S, et al
    The Prognostic Importance of Perioperative Renal Function and Outcome of Patients Undergoing Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  11. KAO A, Linard J, Austin BA, Everley MP, et al
    The Combined Use of Gene Expression Profile and Donor-Derived Cell-Free DNA Testing in the Management of Heart Transplant Patients: The Mid America Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  12. PELED Y, Lavee J, Ram E, Kassif Y, et al
    Left Atrial Volume after Heart Transplantation - A Predictor of Outcomes?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  13. MEGNA D, Emerson D, Cole R, Levine R, et al
    Orthotopic Heart Transplantation in the Diabetic Patient, are We Still Worried? A Review of 952 Consecutive Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  14. KARIM AM, Aljammal M, Panhwar MS, Kalra A, et al
    Impact of Malnutrition and Interventions on Patients Receiving Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  15. KIM H, Kim J, Joo H, Lee S, et al
    The Predictive Scoring Systems for Outcomes of Heart Transplantation in Patients with Pre-Existing Liver Cirrhosis.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  16. LI JP, Kingsford P, Grazette L, Nattiv J, et al
    Heart Transplant Outcomes for Patients with Myocarditis.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  17. SANDOVAL E, Perdomo J, Pereda D, Quintana E, et al
    Has Short-Term Mechanical Circulatory Support an Impact on Post-Heart Transplant Vasoplegia?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  18. AMERI AS, Absi DO, Renedo MF, Giordanino EF, et al
    Outcomes of Heart Transplant in a Sensitized Latin American Population.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  19. AL-SAFFAR F, Hsu J, Fuentes J, Smith J, et al
    Combined AlloSure and AlloMap Testing in Multi-Organ Heart Transplantation Rejection Surveillance.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  20. VAIDYA G, Luthringer D, Czer L
    Giant Cell Myocarditis: Excellent Outcome after Heart Transplant Using Anti-Thymocyte Globulin.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  21. GEORGE S, Horstmanshof DA, Phancao AA, Bedard RA, et al
    Absolute Lymphocyte Count as a Surrogate for Lymphocyte Phenotype Analysis of CD3 Count in Monitoring Thymoglobulin Response Post Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  22. OH J, Chun K, Lee C, Park S, et al
    Morning Surge Was Related with Increased Arterial Stiffness in Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  23. GENUARDI MV, Zhang Y, Mazurek JA, Hanff TC, et al
    Peak Oxygen Consumption and Survival after Heart Transplant is Similar in Patients with and without Comorbid Obstructive Sleep Apnea.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  24. GUPTA R, Punnoose LR, Marvin-Peek J, Schlendorf KH, et al
    Blood Urea Nitrogen to Creatinine Ratio at Listing is Associated with Poor Outcomes in Heart Transplant Recipients with Stage 3 Chronic Kidney Disease.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  25. CHAND RR, Vaidya AS, Lum CJ, Vucicevic D, et al
    Comparing Mortality in Heart Transplantation Utilizing Donor Hearts with and without CAD.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  26. MANING J, Blumer V, Chaparro S
    Protective Effects of Combined Heart Transplantation on Cardiac Allograft Vasculopathy: A Systematic Review and Meta-Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  27. MOAYEDI Y, Fan CS, Purewal S, Han J, et al
    Acute Cellular Rejection after Heart Transplantation Dramatically Subsequent Risk of Mortality, Particularly among African Americans.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  28. IUS F, Sommer W, Rojas SV, Kaufeld T, et al
    Treatment of Anti-HLA Donor-Specific Antibodies in Heart Transplantation: A Single-Center Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  29. HOLMSTROM E, Syrjala S, Krebs R, Nykanen A, et al
    Nitric Oxide Inhalation is Associated with Decreased Incidence of Acute Rejection after Cardiac Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  30. BACAL DC, Silva MMF, de Jesus MS, Bacal F, et al
    C-reactive Protein and Left Ventricular Thickness Can Predict Acute Cellular Rejection after Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  31. LUKAC J, Syrjala S, Saraswat M, Joenvaara S, et al
    Plasma Protein Signature during Ischemia-Reperfusion Injury in Clinical Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  32. SOBIESZCZANSKA-MALEK M, Oleksiak A, Kruk M, Kepka C, et al
    Dynamic Computed Tomography Perfusion for Diagnosis of Cellular Rejection after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  33. DOSHI AH, Tushak Z, Kong H, Garcia V, et al
    Increased Cell Free DNA Levels in African American Patients Early after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  34. GIBLIN G, Murphy L, Mahon N, McCarthy J, et al
    Prevalence of Acute Cellular Rejection and Its Impact on Survival Post Heart Transplantation in the Contemporary Era.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  35. ALVAREZ CK, Nnani D, Patel SR, Goldstein D, et al
    Post-Transplant Diabetes Mellitus and the Risk of Acute Rejection in Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  36. PELED Y, Eilon R, Maor E, Einhorn M, et al
    High Serum Phosphate is Associated with Increased Cardiac Allograft Vasculopathy and Adverse Cardiac Events Following Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  37. GRIFFIN JM, Clerkin KJ, Fried JA, Latif F, et al
    Concordance between Coronary Artery Calcium and Coronary Angiography in the Detection of Cardiac Allograft Vasculopathy in Post Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  38. PATEL J, Kittleson M, Chang D, Nishihara K, et al
    Pre-Transplant Collagen Vascular Disease as a Risk Factor for Increase in Cardiac Allograft Vasculopathy after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  39. LECHIANCOLE A, Sponga S, Vendramin I, Ferrara V, et al
    Coronary Artery Disease of the Donor Graft: Any Impact on Survival and Cardiac Allograft Vasculopathy after Heart Transplantation?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  40. ALHARETHI R, Mason S, Knight S, Min D, et al
    Global Coronary Artery Flow Reserve after Heart Transplantation: Recipient or Donor Age-Driven?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  41. BJERRE KP, Clemmensen TS, Poulsen SH, Hvas A, et al
    Micro and Macrovascular Cardiac Allograft Vasculopathy in Relation to 92 Cardiovascular Biomarkers Evaluated by a Novel Proximity Extension Assay in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  42. DEFILIPPIS EM, Clerkin KJ, Griffin JM, Fried JA, et al
    Sex Differences in Myocardial Flow Reserve by Positron Emission Tomography in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  43. ALAM A, Dib E, Zafar H, Felius J, et al
    Assessment of Coronary Allograft Vasculopathy by Intravascular Ultrasound 6 Weeks and One Year after Heart Transplantation: A Single Center Study.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  44. AIKEN A, Patel J, Kransdorf E, Shen A, et al
    Donor Specific Antibodies after Heart Transplantation: Can They Be Treated?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  45. PANDYA K, Vaidya A, Cheng R, Baran D, et al
    Management of Cardiac Sarcoidosis Post Heart Transplantation: Survey of Transplant Centers.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  46. NATTIV J, Liu GS, Banankhah P, Genyk PA, et al
    Comparison of Six-Month Outcomes in Patients Bridged to Heart Transplantation with an Intra-Aortic Balloon Pump before and after the UNOS Allocation System Change.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  47. MINATO C, Nasri A, Carrier M, White M, et al
    Rapid Weaning of Steroids after Cardiac Transplantation Improves Outcomes.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  48. KOBASHIGAWA JA, Kittleson M, Chang DH, Kransdorf E, et al
    Post-Heart Transplant Outcomes of Sensitized Patients Who Have Undergone Desensitization Therapy.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  49. PATEL J, Kittleson M, Chang DH, Nishihara K, et al
    Does the Dose of Mycophenolate Mofetil Impact Outcome after Heart Transplantation?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  50. SAADI TA, Andrade A, Munro J, Khan M, et al
    Outcomes of Pre- Heart Transplantation Desensitization in Highly Sensitized Patients Bridged with Left Ventricular Assist Devices.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  51. STERLING S, Soto-Arenall M, Goswami R, Patel P, et al
    Evaluation of the Efficacy and Safety of Dual Induction versus Induction Monotherapy in Orthotopic Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  52. COOPER LB, Cochrane A, Cherikh W, Toll AE, et al
    Induction Therapy after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  53. SCATOLA A, Nnani D, Sun E, Alvarez C, et al
    Sirolimus Therapy and Risk of Late Cellular Rejection in Heart Transplant Patients with Cardiac Allograft Vasculopathy.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  54. DELA CRUZ M, Besser S, Sarswat N, Smith B, et al
    Immune Function Testing and Donor-Specific Antibody Production among Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  55. NGUYEN VN, Burt CA, Adler E, Pretorius VG, et al
    Evaluation of Induction Strategies in Heart Transplant at a Single Center.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  56. VAISHNAV E, Pham D, Hess T, Baber A, et al
    Impact of Induction Therapy in Cardiac Transplant Patients in the Current Era.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  57. VOJNIKA J, Vishnevsky A, Shah M, Farzad D, et al
    A Novel Immunosuppressive Regiment for Cardiac Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  58. OH G, Lee H, Oh J, Cho H, et al
    Role of Anti-Vimentin Antibodies in Pre-Sensitized Korean Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  59. DE LA ROSA A, Aguilar J, Barbu A, Chang D, et al
    Uniqueness of Laryngeal Nerve Injury Following Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  60. SON AY, Karim AS, Cerier E, Bharadwaj SN, et al
    Outcomes of Heart Transplantation Bridging Strategies: Durable VAD vs IABP vs Medical Therapy.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  61. LUNDGREN S, Lowes B, Lyden E, Zolty R, et al
    Pre-Heart Transplant Spirometry Predicts Post-Transplant Survival.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  62. NISHIDA H, Ota T, Koda Y, Onsager D, et al
    Long Term Survival after Heart Transplantation is Not Affected by Axillary Intra Aortic Balloon Pump Support as a Bridge to Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  63. CHANG E, Moayedi Y, Hoppenfeld M, Lafreniere-Roula M, et al
    Malignancy Following Heart Transplant: Few and Far Between.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  64. FUKUSHIMA N, Yanase M, Watanabe T, Kuroda K, et al
    Mid-Term Effectiveness of Everolimus on Heart Transplant Recipients with Renal Dysfunction or Transplant Coronary Artery Atherosclerosis.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  65. RODRIGUEZ JBC, Argueta E, Santana HM, Lenneman A, et al
    Incidence and Onset of Leukopenia in Adults the First Year after Orthotopic Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  66. BARTEN MJ, Hong J, Hua X, Bernhardt A, et al
    Long-Term Results of Everolimus on Renal Function and Rejection after Heart Transplantation in a Real-Life Scenario.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  67. KINGSFORD P, Li JP, Wolfson AM, Nattiv J, et al
    Heart Transplantation Outcomes in Multiorgan Transplants.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  68. LIU G, Wolfson AM, Nattiv J, Genyk P, et al
    Post-Transplant Outcomes for Patients Based on Their Duration of Smoking Cessation at the Time of Heart Transplant (HT) Listing.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  69. GUPTA N, McDonald MA, Kobashigawa JA, Ross HJ, et al
    Cannabis Use and Heart Transplantation: A Canadian Perspective.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  70. PELED Y, Ram E, Kogan A, Kassif Y, et al
    Combined Procurement of Heart and Lungs is Associated with an Increased Risk of Primary Graft Dysfunction after Heart Transplantation Compared to Isolated Heart Procurement.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  71. RAMZY D, Esmailian F, Emerson D, Megna D, et al
    Has the New Heart Transplant Donor Allocation Policy Affected Immediate Post-Transplant Care and Outcomes? A Single Center Perspective.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  72. MURANA G, Fiorentino M, Gliozzi G, Botta L, et al
    Impact of Current Donor Scores Calculation on Heart Transplantation Outcomes.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  73. EMERSON D, Megna D, Cole R, Levine R, et al
    Does Brain Death Related to Underlying Donor Disease Correlate with Adverse Outcomes after Heart Transplant?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  74. MAGRUDER J, Sperry A, Vasquez CR, Smood BF, et al
    Impact of Multiorgan Procurement on Survival Following Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  75. KAO A, Wells R, May A, Markham L, et al
    The Effect of the New UNOS Heart Allocation on Donation Service Area and Heart Transplant Program Logistics: The Mid America Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  76. FIEDLER AG, Lushaj EB, Dhingra R, Hermsen JL, et al
    30 Day Survival in Heart Transplant Patients Bridged with Short Term Mechanical Circulatory Support: Are We Failing to Rescue?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  77. STINSON G, Patel PC, Yip DS, Leoni-Moreno JC, et al
    Assessment of Aortic Root Size in Donor Heart Predicts Short and Long Term Recipient Outcomes after Orthotopic Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  78. FIEDLER AG, Smith JW, Raza F, Hermsen JL, et al
    Differences in Heart Transplant Volume Growth and Outcomes among Low and High Volume Centers.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  79. GONCALVES FAR, Trindade EM, Mangini S, Gaiotto F, et al
    Impact of Histidine-Tryptophan-Ketoglutarate Preservation Solution in Heart Transplantation with Extended Distance.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  80. PANDYA K, Rahman J, Vaidya A, Fong M, et al
    Utilization of Public Health Service Increased Risk Donors in Heart Transplantation and Outcomes: UNOS Registry Review.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  81. NATTIV J, Banankhah P, Liu GS, Genyk PA, et al
    Outcomes Using Veno-Arterial Extra-Corporeal Membrane Oxygenation as a Bridge to Heart Transplantation Following the UNOS Allocation Policy Change.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  82. PATEL J, Kittleson M, Kransdorf E, Shen A, et al
    Does the Development of Donor Specific Antibody after Heart Transplantation Depend on the Presence or Absence of Corticosteroids as Maintenance Therapy?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  83. PATEL J, Kittleson M, Chang DH, Nishihara K, et al
    5-Year Outcome of Patients Weaned off Corticosteroids after Heart Transplantation: Is There a Downside?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  84. VENEMA CS, Erasmus ME, Mariani M, Voors AA, et al
    Inotrope Score as a Predictor of Outcome after Adult Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  85. HUCKABY LV, Aranda-Michel E, Seese LM, Keebler M, et al
    Contemporary Sex-Based Outcomes after Orthotopic Heart Transplantation for Patients Bridged with Newer Generation Left Ventricular Assist Devices.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  86. LIU GS, Wolfson AM, Nattiv J, Genyk PA, et al
    Heart Transplant Outcomes for Patients with Cardiac Sarcoidosis.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  87. BRAUTASET ENGLUND KV, Ostby CM, Vartdal T, Rolid K, et al
    Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients (IronIC) - A Randomized, Double Blind, Controlled Trial.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  88. BUCHAN TA, Moayedi Y, Truby LK, Posada JD, et al
    Incidence and Impact of Primary Graft Dysfunction in Adult Heart Transplant Recipients: A Systematic Review and Meta-Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  89. CHEN Y, Chi N, Wang C, Yu H, et al
    Double Bridge May Result Similar 3-year Outcome after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  90. TIBREWALA A, Khush KK, Cherikh W, Foutz J, et al
    Risk of Renal Dysfunction Following Heart Transplantation in Patients Bridged with Left Ventricular Assist Devices.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  91. LIM S, Shaw S, Venkateswaran R, Abu-Omar Y, et al
    HeartMate 3 Compared to Heart Transplant Outcomes in England.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  92. EDELSON JB, Edwards JJ, Katcoff H, Mondal A, et al
    Comparing Resource Use and Outcomes between Patients with Ventricular Assist Devices and Orthotopic Heart Transplant in the United States from 2006-2014: A Nationally Representative Sample of Emergency Department Visits.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  93. GOLDWATER D, Ventigan N, Shih L, Jaladanki S, et al
    Feasibility of Incorporating Frailty Testing into Standard Assessment of Heart Transplant Candidacy.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  94. MOSCARELLO TG, Moayedi Y, Caleshu C, Khush K, et al
    You Can't Find What You Aren't Looking For: Over Half of Heart Transplant Patients Have Moderate or Strong Likelihood of Genetic Disease.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  95. CHATURVEDI A, Patel K, Vashistha K, Kanwar M, et al
    Post-Cardiac Transplant Lymphocytic Thyroiditis Secondary to Amiodarone Use in the Pre-Transplant Period.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  96. WU R, Weston M, Lunz JG, Lopez-Cepero M, et al
    A Mismatch Made in Medicine: Potential Implications of HLA DQ Epitope Mismatching Following Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  97. MORRIS KL, Adlam JP, Haleem A, Patel A, et al
    Tacrolimus Levels after Direct Acting Anti-Viral Therapy in Hepatitis C Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  98. GENYK PA, Liu GS, Nattiv J, Banankhah P, et al
    Heart Transplant Outcomes in Patients Who Receive Hepatitis B Virus (HBV) Positive Donor Hearts.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  99. GENYK PA, Nattiv J, Liu GS, Vucicevic D, et al
    Outcomes of Heart Transplantation in Adults with Congenital Heart Disease Since UNOS Allocation System Change: UNOS Registry Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  100. LIU G, Wolfson AM, Nattiv J, Genyk PA, et al
    Comparison of Six-Months Outcomes in Patients Bridged to Heart Transplant with Inotropes before and after UNOS Heart Allocation Policy Change.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  101. BANANKHAH P, Nattiv J, Liu GS, Genyk PA, et al
    Six-Month Outcomes for Patients Bridged to Heart Transplantation with Veno-Arterial Extra-Corporeal Membrane Oxygenation before and after the Heart Allocation Policy Change.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  102. XIN L, Yao W, Yu F, Ribeiro RV, et al
    Comparison of Lactate and Glucose during Ex Situ Heart Perfusion as Predictors of Early-Stage Heart Transplantation Outcomes.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  103. PELED Y, Ram E, Klempfner R, Lavee J, et al
    Weight Gain Following Heart Transplantation is Associated with Increased Risk of Rejection and Allograft Vasculopathy: An Analysis of the ISHLT Registry.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  104. PUNNOOSE L, Coscia LA, Kliniewski D, Constantinescu S, et al
    Update on Pregnancy after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  105. AGASTHI P, Smith SD, Murphy KM, Buras MR, et al
    Artificial Intelligence Helps Predict 5-year Mortality and Graft Failure in Patients Undergoing Orthotopic Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  106. URIEL N, Benza R, Raval N
    The Effect of Pre-Transplant Mechanical Circulatory Support Devices on the Post-Transplant dd-cfDNA and GEP in Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  107. ALTSHULER PJ, Helmers M, Iyengar A, Han J, et al
    HCV Seropositive Donors Positively Impact Heart Transplantation Rates and Waitlist Mortality without Compromising Outcomes.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  108. NATTIV J, Liu GS, Banankhah P, Genyk PA, et al
    Intermediate Survival Outcomes after Heart Transplantation Using Donor HCV NAT Positive Hearts.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  109. LI SS, Moonsamy P, Osho A, Mohan N, et al
    Outcomes of Heart Transplantation from Hepatitis C Seropositive Donors: An Updated Analysis of the United Network for Organ Sharing Registry.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  110. STACHEL MW, Gidea CG, Katz S, Narula N, et al
    Incidence of Acute Cellular Rejection in Heart Transplant Recipients from Hepatitis C Viremic Donors - One-Year Follow-Up.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  111. KADOSH B, Gidea C, Reyentovich A, Razzouk L, et al
    Cardiac Allograft Vasculopathy in Heart Transplant Recipients from Hepatitis C Viremic Donors.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  112. WINGO M, de Biasi AR, Shudo Y, Lingala B, et al
    Cardiac Transplantation for Cancer Involving the Heart: Results from 35 Years of Transplants from the ISHLT Registry.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  113. GIULIANO K, Canner JK, Etchill EW, Suarez-Pierre A, et al
    De Novo Malignancy after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  114. KIM I, Rossano JW, Kim H, Kim J, et al
    Predictors and Clinical Outcomes of Lymphoproliferative Disorders in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  115. KUNO T, Ueyama H, Takagi H, Alvarez P, et al
    Comparative Outcomes of Maintenance Immunosuppression Regimens in Heart Transplantation: Insights from Network Meta-Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  116. UYANIK-UENAL K, Perkmann-Nagele N, Wittmann F, Ceran E, et al
    Torque Teno Virus DNA Load after Heart Transplantation and Its Association with the Strength of Immunosuppression: Preliminary Data of a Prospective Single Center Study.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  117. ROCHLANI YM, Miller A, Nnani D, Oh KT, et al
    Mycophenolate Mofetil Dose and Early Acute Cellular Rejection Post Cardiac Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  118. GANAPATHI AM, Whitson BA, Lampert B, McLaughlin B, et al
    Impact of Preoperative Mechanical Support Following Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  119. PAGE A, Messer S, Berman M, Kaul P, et al
    Heart Transplantation from Donation after Circulatory Determined Death: The Royal Papworth Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  120. NILSSON J, Jernryd V, Qin G, Paskevicius A, et al
    Non-Ischemic Heart Preservation versus Static Cold Storage in Human Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  121. HANFF TC, Harhay MO, Kimmel SE, Molina M, et al
    VA-ECMO as a Bridge to Heart Transplantation: Quantification of Mortality Trends over the Last Decade.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  122. POPTSOV VN, Spirina EA, Dogonascheva AA
    Five Years Experience of Peripheral Veno-Arterial ECMO as Method of Mechanical Circulatory Support in Heart Transplant Candidates.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  123. ADLAM JP, Morris K, Salerno CT, Walsh MN, et al
    First Reported Treatment Failure in a Recipient of a Hepatitis C Viremic Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  124. CALLAN PD, Yonan N, Santhanakrishnan K, Shaw SM, et al
    Does CMV Status Impact on Morbidity and Survival Following Heart Transplantation? A Large Multi-Centre Retrospective UK Study.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  125. PUING A, Couture-Cosette A, Quintero O, Multani A, et al
    6-month vs 12-month CMV Prophylaxis for CMV-Mismatched Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  126. GENYK PA, Nattiv J, Liu GS, Banankhah P, et al
    Heart Transplantation Outcomes in Patients with Marfan Syndrome: UNOS Registry Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  127. PELED Y, Ram E, Klempfner R, Lavee J, et al
    Clinical Predictors, Regional Variation and Temporal Trends of Weight Gain after Heart Transplant: An Analysis of the ISHLT Transplant Registry.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  128. KITTLESON M, Patel J, Kransdorf E, Shen A, et al
    Is Anti-Thymocyte Globulin for Sensitized Patients Undergoing Heart Transplantation Effective?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  129. SURYAPALAM M, Kashem MA, Zhao H, Sunagawa G, et al
    Heart Transplantation in Elderly Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  130. DIAMANT MJ, Fox AL, Modi VA, Joshi AA, et al
    No Survival Benefit Associated with Waiting for Non-Lung Donor Heart Transplants for Recipients with Adult Congenital Heart Disease.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  131. KAINUMA A, Sanchez J, Ning Y, Nemeth SK, et al
    Contemporary Outcomes of Heart Transplantation in Adult Patients with Congenital Heart Disease and Prior Intracardiac Repair: Analysis from UNOS Database.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  132. KURIATA J
    Circulating miRNA 208a Reflect Early Myocardial Injury and Recovery after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  133. GENYK P, Nuno SB, Hashmi S, Nattiv J, et al
    Heart Transplant Outcomes in Patients with Alcoholic Cardiomyopathy.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  134. GOEKLER J, Zuckermann A, Worel N, Ceran E, et al
    Extracorporeal Photopheresis Immediately after Heart Transplantation in High Risk Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  135. KENNEDY CC, Lee M, Hathcock M, Thompson K, et al
    Self-Management Ability is an Indirect Mediator of Quality of Life in Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  136. MARSH KM, Mehaffey J, Krebs ED, Beller JP, et al
    Long Term Employment Following Heart Transplantation in the United States.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  137. SINGHVI A, Araujo-Gutierrez R, Park MH, Bhimaraj A, et al
    Prognostic Value of Dobutamine Stress Echocardiography in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  138. HUPF JC, Onat D, Javaid A, Mondellini GM, et al
    Association of Plasma Trimethylamine-N-oxide and Serum Endothelin-1 with Cardiac Allograft Vasculopathy in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  139. GOURZI P, Pantou MP, Gkouziouta A, Chaidaroglou A, et al
    Can Genetic Profile of Patients Undergoing Heart Transplantation Alter Clinical Decisions?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  140. PARIZO J, Khush K
    Donor Derived Cell Free DNA Levels are Predictive of Clinical Events in Stable Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  141. DE OLIVEIRA FM, Ikeda ET, Avila M, Wozniak I, et al
    Prevalence of Cognitive Impairment in Heart Transplant Waiting-List Patients in a Developing Country.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  142. ZAVER SM, Wan JY, Lei D, Whitson BA, et al
    Improving Heart Transplant Outcomes in the African American Population? Are We There Yet?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  143. PELED Y, Beigel R, Klempfner R, Lavee J, et al
    Prevalence and Clinical Predictors of Aspirin Resistance in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  144. LIU Y, Padilla FA, Graviss EA, Nguyen D, et al
    Heart Transplant Outcomes in Obese Patients BMI 35-39.9.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  145. ROLID K, Andreassen AK, Yardley M, Bjorkelund E, et al
    Effect of High-Intensity Interval Training in De Novo Heart Transplant Recipients - 3-year Results from the HITTS Randomized Controlled Trial.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  146. BARGHASH MH, Taimur S, Rana M, Behar J, et al
    Recombinant Herpes Zoster Vaccine (RZV) after Heart Transplantation: A Single Center Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  147. COUTANCE G, Boutolleau D, Rouvier P, Leprince P, et al
    Cytomegalovirus Infections are Frequent after Heart Transplantation but Do Not Increase the Risk of Biopsy-Proven Allograft Rejection in the Modern Era.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  148. SIROTA M, Heyrend C, Ou Z, Masotti S, et al
    Tacrolimus Trough Variability- Predictors and Outcomes in Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  149. TOWNSEND ML, Karamlou T, Boyle GJ, Feingold B, et al
    Brighter Future for Children with Congenital Heart Disease Requiring Heart Transplantation? A UNOS Registry Analysis over the Last Three Decades.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  150. THANGAPPAN K, Price N, Zafar F, Alsaied T, et al
    Congenital Heart Disease and a Single Lung: Is Heart Transplantation Alone an Option?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  151. ALMOND C, Sleeper LA, Rossano JW, Pahl E, et al
    The TEAMMATE Trial: Study Design and Rationale of the First Pediatric Heart Transplant Randomized Clinical Trial.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  152. ZELLERS TM, Daneman S, Butts R
    Gene Expression Profiling Scores (Allomap) Can Successfully Predict the Absence of Serious Rejection in a Pediatric Heart Transplant Population; Single Center Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  153. WALDMAN G, Gift T, Turvey K, Ho JE, et al
    Optimal Dosing of Enoxaparin to Achieve Therapeutic Anticoagulation in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  154. SRIWATTANAKOMEN R, Xu Q, Zeevi A, Demehin M, et al
    Carfilzomib for Heart Transplant Desensitization.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  155. SALAH LM, Oreschak K, Ambardekar AV, Page RL 2nd, et al
    Effect of CYP3A Genetic Variants on Different Measures of Tacrolimus Variability in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  156. HANERHOFF MC, Dreyer WJ, Denfield SW, Choudhry S, et al
    Assessment of Mycophenolic Acid Levels on Biopsy Proven Rejection and Adverse Effects in Pediatric Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  157. THANGAPPAN K, Morales DL, Lehenbauer D, Villa C, et al
    Impact of Mechanical Circulatory Support on Pediatric Heart Transplant Candidates with Elevated Pulmonary Vascular Resistance.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  158. RASKIN A, Borsheim K, Kim M, Brickler M, et al
    Plasma Induced Transcriptional Analysis Assessment of Rejection in Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  159. DESHPANDE SR, Alsoufi B, Sinha P, Amdani S, et al
    Do Expanded Donor Criteria Impact Outcomes in Pediatric Heart Transplantation? A UNOS Registry Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  160. NAKANO SJ, Zhou J, Nunley K, Beatty J, et al
    Polyfunctional CD8+ T Cells are Associated with Biopsy Proven Acute Cellular Rejection in Pediatric Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  161. GENYK PA, Liu GS, Nattiv J, Banankhah P, et al
    Heart Transplantation Outcomes in Adults with Postpartum Cardiomyopathy.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  162. JENNINGS DL, Pinsino A, Mahoney I, Sweat A, et al
    Use of Serum Cystatin C versus Creatinine for Estimation of Renal Function and Valganciclovir Dosing in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  163. POGLAJEN G, Frljak S, Zemljic G, Okrajsek R, et al
    Clinical Effects of CD34(+) Cell Therapy in Advanced Chronic Heart Failure Patients Listed for Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  164. LEE J, Cho Y, Park I
    Heart Transplantation Bridged by Extracorporeal Life Support in the Korean Adults: A 15 Year Single Center Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  165. PADILLA MMM, Hayes E, Hodge A, Meyer E, et al
    A Comparison of Intra-Operative Human Leukocyte Antigen Antibody Removal Techniques in Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  166. PIECHURA LM, Harloff MT, Keshk M, Ogawa M, et al
    A Contemporary Analysis of the Safety and Efficacy of Cardiac Transplantation from Donors with Blood Infections.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  167. NATTIV J, Liu GS, Banankhah P, Genyk PA, et al
    Long-Term Survival Outcomes after Heart Transplantation in Patients with Chagas Cardiomyopathy.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  168. CHOW JK, Ruthazer R, Boucher HW, Nierenberg N, et al
    Factors Associated with Neutropenia Post-Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  169. RAHMAN F, Dunn D, Baneman E, Sullivan T, et al
    Strongyloides Screening in Heart Transplant Candidates.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  170. TRUJILLO D, Ruiz L, Jaramillo A, Alejandro C, et al
    Survival in the First Year of Heart Transplantation in a Center of a Developing Country, Infection versus Rejection as Causes of Mortality.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  171. GRANEY N, Paliga R, Siemeck R, Glowacki N, et al
    Impact of Ventricular Assist Device Infection Severity on 1-Year Survival after Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  172. ROLID K, Andreassen AK, Yardley M, Bjorkelund E, et al
    Benefits of High-Intensity Interval Training in a Young and in an Older De Novo Heart Transplant Recipient- Cases from the HITTS Study.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  173. BURNETTE AL, Henderson HT, Adams VL, Savage AJ, et al
    The Use of Concurrent Home Hospice for Pediatric Heart Failure Patients Awaiting Heart Transplant on Milrinone and/or Ventricular Assist Device.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  174. MABASA AC, Kleet AC, Gaine M, Lee JC, et al
    Follow-Up Phone Calls are Effective in Increasing Compliance with Screening for De Novo Cancer among Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  175. BARTEN MJ, Hua X, Bernhardt A, Rybczynski M, et al
    Optimal Dosing of Cyclosporine and Tacrolimus to Improve Medication Adherence after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  176. BARRETT AL, Gilbert KE, Hope K, Spinner JA, et al
    Think Ahead! A Quality Improvement Initiative for Advance Directives in Young Adult Heart Transplant Recipients at a Pediatric Center.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  177. DALVINDT M, Nozhoor S, Kisch A, Forsberg A, et al
    Chronic Pain One to Five Years after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  178. FORSBERG A, Paulsson A, Ragntoft C, Dalvindt M, et al
    Fear of Graft Rejection after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  179. MILLER RJ, Hedman K, Vrotec B, Ingelsson E, et al
    Novel Methods for Donor and Recipient Size Matching in Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  180. VAN DEN HOOGEN P, Huibers MM, van den Dolder FW, de Weger RA, et al
    Plasma Immunoglobulin Levels Prior to Cardiac Transplantation are Associated with Post-Transplantation Survival.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  181. FEDRIGO M, Carrozzini M, Bocca T, Bottigliengo D, et al
    Rejection Profile on Endomyocardial Biopsy in the Follow Up of Heart Transplanted Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  182. WESTON M, Rinde-Hoffman D, Berman P, Arroyo L, et al
    Heart Transplant Patients with PAMR1(H+) and PAMR2 Rejection Have the Same Amount of Myocardial Injury by Molecular Microscope.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  183. ORTIZ-GONZALEZ Y, Yip DS, Patel PC, Leoni-Moreno JC, et al
    Evaluation of Infection Risk Based on Induction Immunotherapy within the First Year after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  184. NGUYEN A, Rodgers D, Imamura T, Besser S, et al
    Prevalence of BK Virus Infection in a Large Heart Transplant Population.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  185. FUJINO T, Kumai Y, Nitta D, Lourenco L, et al
    Hypogammaglobulinemia Following Heart Transplantation - Prevalence and Clinical Importance.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  186. DAS BB, Winchester R, Niu J
    Is There Any Role of Gene Expression Profiling Test in Asymptomatic Pediatric Heart Transplant Recipients?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  187. KUHN MA, Chau P, Gordon BR, Martens TP, et al
    Utility of Early Intravascular Ultrasound after Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  188. RATHGEBER SL, Hutchison S, De Souza AM, Timothy O, et al
    Using Text Messaging to Communicate with Adolescent Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  189. BARKOFF LM, Dykes JC, Maeda K, Hollander SA, et al
    Taking a Closer Look at Distance: Does Increasing the Maximal Donor Distance Range Shorten Waitlist Times in Pediatric Heart Transplant Candidates?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  190. BHIMANI S, Boyle G, Liu W, Worley S, et al
    Gender and Racial Disparities in Pediatric Heart Transplantation in the Current Era: A UNOS Registry Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  191. IQBAL MS, Zhang Y, Dykes J, Almond C, et al
    Impact of Insurance Status on Pediatric Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  192. HOPE KD, Choudhry S, Puri K, Spinner JA, et al
    Atypical Infiltrates on Endomyocardial Biopsy are Associated with Adverse Outcomes in Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  193. KIRK C, Tong M, Shivaram G, Law Y, et al
    Herding CATs? The Incidence and Prevention of Catheter-Associated Thromboses (CATs) in Pediatric Patients after Cardiac Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  194. DESHPANDE SR, Simpson PM, Zhang L, -Mitchell AT, et al
    Natural History of Hemodynamic Maturation Post Heart Transplantation in the Absence of Rejection.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  195. KOPECKY B, Lavine K
    Investigating the Roles of Donor Macrophages after Cardiac Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  196. ZAR G, Vihinen M, Nilsson J
    Identify New Genetic Variants on Chromosome 6 Associated with Mortality after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  197. MANTELL BS, Cordero H, See S, Clerkin K, et al
    RNA Expression Analysis of Antibody Mediated Rejection after Heart Transplant with or without Donor Specific Antibodies.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  198. RAVICHANDRAN R, Itabashi Y, Liu W, Mohanakumar T, et al
    Role for Circulating Exosomes with Cardiac Self-Antigens (Myosin and Vimentin) in the Pathogenesis of Chronic Rejection in a Murine Heterotopic Model of Cardiac Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  199. PATEL J, Kittleson M, Chang DH, Nishihara K, et al
    The Forgotten Hepatitis B Donor in Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  200. KITTLESON M, Patel J, Chang D, Nishihara K, et al
    Effect of the Shingles Vaccine in Altering Clinical Shingles after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  201. PELED Y, Lavee J, Maor E, Freimark D, et al
    Hepatitis B Seropositivity is Associated with Increased Cardiac Allograft Vasculopathy after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  202. MOSS I, Brueckner A, Rumore A
    Comparison of Outcomes in Heart Transplant Recipients Receiving CMV Prophylaxis with CMV IVIG with Valganciclovir versus Valganciclovir Alone.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  203. LAU RP, Sosa RA, Fishbein GA
    Sarcolemmal Staining by Anti-C4d/C3d in Cardiac Transplant Endomyocardial Biopsies and Associated Serum HLA Antibodies and Pathologic Rejection.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  204. JENNINGS DL, Salerno D, Lange N, Clerkin KJ, et al
    Faster Time-to-Therapeutic Tacrolimus Level is Associated with Lower Risk of Cellular Rejection Early after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  205. KIM M, Givertz MM, Stewart GC, Page DS, et al
    Efficacy and Safety of LCP-Tacrolimus (Envarsus XR(R)) Conversion Therapy in Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  206. RAMZY D, Esmailian F, Emerson D, Megna D, et al
    The New UNOS Heart Allocation Changes Significantly Changed the Landscape of Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  207. XIA Y, Regalie W, Nsair A, Ardehali A, et al
    Characteristics and Outcomes of Heart Transplants Following the Change in UNOS Allocation Policy.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  208. LEACCHE M, Boeve TJ, Manandhar Shrestha N, Kelty CE, et al
    Changing Landscape of Heart Transplantation in the US after Implementation of the New Allocation System: A UNOS Data Registry Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  209. NELSON LM, Rossing K, Boesgaard S, Gustafsson F, et al
    Early IVUS-Guided Selection for Non-Invasive Cardiac Allograft Vasculopathy (CAV) Screening in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  210. ASLEH R, Briasoulis A, Smith B, Lopez C, et al
    Effects of Aspirin on Progression of Cardiac Allograft Vasculopathy and Outcomes after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  211. NAGUMO S, Gallinoro E, Candreva A, Mizukami T, et al
    Virtual Fractional Flow Reserve in Heart Transplant Recipients with and without Graft Vasculopathy.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  212. ROEST S, Nous FM, van Dijkman ED, Attrach M, et al
    Use of Cardiac CT in the Routine Assessment of Cardiac Allograft Vasculopathy in Heart Transplant Patients: Results from the First 100 Consecutive Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  213. LIU GS, Wolfson AM, Genyk PA, Vucicevic D, et al
    Outcomes of HIV-Positive Patients Post Cardiac Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  214. BEARL DW, Cantor R, Koehl D, Gossett JG, et al
    Heart Transplant Outcomes in Children with Fontan-Associated Plastic Bronchitis: A Pediatric Heart Transplant Society Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  215. BOGLE C, Cantor R, Koehl D, Lochridge J, et al
    Obesity Leads to Increased Mortality in Pediatric Heart Transplant Recipients - A Pediatric Heart Transplant Society Study.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  216. AMDANI S, Staffa SJ, Zurakowski D, Ramakrishnan K, et al
    ABO Incompatible Heart Transplantation in Pediatric Recipients with High Isohemagglutinin Titers in the U.S.: A Multi-Institutional Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  217. POWER A, Sweat KR, Hollander SA, Schmidt J, et al
    Waitlist Mortality in US Children Listed for Heart Transplant - Where are We Now?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  218. LIN CM, Mehrad B, Gill RG
    The Natural Killer Cell Receptor NKG2D is Critical to Antibody-Mediated Chronic Rejection in Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  219. LICHSCHEIDT ED, Jespersen NR, Nielsen BR, Berg K, et al
    Mitochondrial Function is Impaired in Heart Transplant Patients with Cardiac Allograft Vasculopathy.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  220. DEW MA, DeVito Dabbs AJ, DiMartini AF, Ma Y, et al
    Health-Related Quality of Life Impairments and Benefits 15-19 Years after Lung or Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  221. ORESCHAK K, Saba LM, Deininger KM, Ambardekar AV, et al
    Association between Variants in Calcineurin Inhibitor Pharmacokinetic and Pharmacodynamic Genes and Renal Dysfunction in Adult Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  222. POGLAJEN G, Zemljic G, Frljak S, Okrajsek R, et al
    Prolonged Release Tacrolimus Has Comparable Safety and Efficacy Profile as Standard Release Tacrolimus in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  223. CASCINO T, Stehlik J, Cherikh W, Cheng Y, et al
    Mechanical Circulatory Support Use in the Context of Updated Heart Transplant Allocation Policy in the U.S. - Analysis of OPTN Data.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  224. HANFF TC, Harhay MO, Kimmel SE, Molina M, et al
    The Role of Human Leukocyte Antigen Sensitization as a Risk Factor for Mortality in Patients Bridged to Heart Transplantation with VA-ECMO.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  225. PUREWAL S, Moayedi Y, Runeckles K, Fan C, et al
    Are Two Tests Better Than One? Combining Donor Derived Cell-Free DNA and Gene Expression Profiling for Non-Invasive Surveillance after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  226. BOYLE K, Pollack A, Brinkley D
    Lymphocyte Suppression in Heart Transplant Recipients after Thymoglobulin Dosing Based on CD3+ Lymphocyte Counts.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  227. HO S, Ly P, Riesgo-Gil F, Dar O, et al
    Incidence and Risk Factors for Neutropenia in Adult Heart Transplant Recipients: Single Centre Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  228. SEESE L, Aranda-Michel E, Huckaby L, Keebler M, et al
    Development and Validation of a Risk Score to Predict One-Year Mortality after Bridge to Heart Transplantation with Contemporary Durable Left Ventricular Assist Devices.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  229. MASETTI M, Moretta A, Sabatino M, Russo A, et al
    Pulmonary Vascular Resistances among Heart Transplant Candidates: Are We Looking to the Right Player?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  230. FIEDLER AG, Smith JW, Raza F, Hermsen JL, et al
    Significant Regional Variability Yet Similar Survival in Heart Transplantation Utilizing Increased Risk Donor Hearts.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  231. GANAPATHI AM, Whitson BA, LaFrancesca S, McLaughlin B, et al
    The Effect of Donor Heart Risk Factors on Cardiac Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  232. HALLORAN PF, Reeve J, Aliabadi A, Cadeiras M, et al
    Mapping the Injury Phenotypes of Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  233. GLASS C, Davis R, Xiong B, Dov D, et al
    The Use of Artificial Intelligence (AI) Machine Learning to Determine Myocyte Damage in Cardiac Transplant Acute Cellular Rejection.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  234. FEDRIGO M, Bottigliengo D, Romano A, Gugole E, et al
    Clinical Relevance of Vasculitis in Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  235. CLERKIN KJ, Griffin JM, Fried JA, Restaino SW, et al
    Myocardial Flow Reserve by N13 Ammonia Positron Emission Tomography Predicts Post-Heart Transplant Outcomes.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  236. WAN N, Travin M, Luke A, Gjelaj C, et al
    Poor Glycemic Control Correlates with Worse Myocardial Flow Measured by Ammonia-13 Positron Emission Tomography in Cardiac Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  237. CLERKIN KJ, Fried JA, Griffin JM, Restaino SW, et al
    Impact of Time Post-Heart Transplant on Myocardial Flow Reserve and Outcomes.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  238. BUDDE R, Nous F, Roest S, Constantinescu A, et al
    Non-Invasive Functional Coronary Artery Evaluation by CT-Derived Fractional Flow Reserve (FFRct) in Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  239. BRUSCA SB, Jang MK, Shah P, Shah KB, et al
    Early Donor-Derived Cell-Free DNA Predicts Peak Allograft Function in Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  240. KEMNA MS, Shaw D, Ameduri R, Azeka E, et al
    Posterior Reversible Encephalopathy Syndrome (PRES) after Pediatric Heart Transplantation: A Multicenter Study.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  241. GRIFFITHS ER, Schumacher K, DiPaola F, Chen S, et al
    The Fontan Liver after Cardiac Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  242. HEDE S, Fraschilla S, Alejos JC
    Development and Utility of a Novel Post-Operative Pediatric Heart Transplant Clinical Pathway.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  243. WALDMAN G, Bethea E, Gustafson J, Cote M, et al
    Use of Crushed Glecaprevir/Pibrentasvir in Hepatitis C Positive Donor Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  244. ESMAILY S, Dellgren G, Bobbio E, Nilsson J, et al
    Patient Outcomes after Heart Transplantation in Sweden between 1988 and 2017: Continuous Improvement in Survival.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  245. SINGHVI A, Araujo-Gutierrez R, Bhimaraj A, Park MH, et al
    Influence of HLA-DR Mismatches on Long Term Outcomes Following Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  246. CHAND RR, Vaidya AS, Lum CJ, Vucicevic D, et al
    Heart Transplantation Mortality in Recipients with Muscular Dystrophy.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  247. SHAH M, Patel S, Saeed O, Pirlamarla P, et al
    Impact of Center Heart Transplant Volume on One-Year Survival or Retransplantation: A 2006 to 2016 UNOS Based Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  248. SHAH M, Villela MA, Bravo C, Castellanos A, et al
    Impact of Donor Hemodynamics on Heart Transplant Outcomes: Using Machine Learning Techniques.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  249. VILLELA MA, Bravo CA, Shah M, Patel S, et al
    Prediction of Outcomes after Heart Transplantation Using Machine Learning Techniques.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  250. BOUNADER K, Flecher E, Chabanne C, Lelong B, et al
    Ratio of Pulmonary Artery Diameter to Ascending Aortic Diameter as a Predictive Tool for Severe Primary Graft Dysfunction in Heart Transplants.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  251. LIM S, Chue CD, Mukadam ME, Quinn D, et al
    Cardiac Power Output Index to Define Severe Graft Dysfunction in Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  252. PELED Y, Ram E, Kogan A, Kassif Y, et al
    Spontaneous Restoration of Sinus Rhythm during Heart Transplantation is Associated with a Reduced Incidence of Primary Graft Dysfunction and Early Mortality.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  253. KRISHNAMOORTHY B, Mehta V, Critchley WR, Callan P, et al
    Clinical Outcomes and Financial Implications of Using Extra Corporeal Membrane Oxygenation (ECMO) for Primary Graft Dysfunction Following Heart Transplantation: A Single Centre Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  254. KITTLESON M, Patel J, Chang D, Kransdorf E, et al
    Outcome of Right Ventricular Primary Graft Dysfunction after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  255. KITTLESON M, Patel J, Chang D, Nishihara K, et al
    Longer-Term Morbidity/Mortality of Severe Left Ventricular Primary Graft Dysfunction after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  256. BOEKEN U, Aubin H, Mehdiani A, Bottger C, et al
    Levosimendan Treatment in Patients with Primary Graft Dysfunction after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  257. MORENO J, Verma A, Kopecky B, Dehner C, et al
    Angiotensin II Type 1 Receptor Antibody Mediated Rejection Following Orthotopic Heart Transplant: A Single Center Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  258. BROWN KD, Cooper C, Arce-Esquivel AA, Gottlieb RL, et al
    Impact of Ischemic Time on Functional Exercise Capacity after Orthotopic Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  259. RAVI Y, Chinta V, Zaver SM, Balasubramaniyan JV, et al
    Do Post- Heart Transplant Placement of Permanent Pacemakers Affect Survival?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  260. LEVA E, Syrjala S, Kytola S, Kankainen M, et al
    Donor-Derived Cell-Free DNA as an Early Noninvasive Biomarker of Cardiac Allograft Injury and Rejection in Human Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  261. KEARNS MJ, Chou L, Aguillon M, Passano E, et al
    Impella 5.0 as a Bridge to Cardiac Transplantation before and after Reclassification of the United Network for Organ Sharing Heart Allocation Criteria.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  262. SYMALLA T, Song T, Ota T, Mirzai S, et al
    Negative Outcomes Associated with Reoperative Sternotomy and LVAD Explantation at the Time of Cardiac Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  263. URBAN M, Lundgren S, Siddique A, Lowes B, et al
    Long-Term Outcome of Heart Transplant Recipients with Acute Graft Dysfunction Requiring Temporary Mechanical Circulatory Support.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  264. KAWABORI M, Critsinelis AC, Nordan T, Chen FY, et al
    UNOS Registry Study: The Impact of Preoperative Mechanical Circulatory Support Devices to Heart Transplant Outcomes in over 78,000 Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  265. MAZZONE S, Fujino T, Nguyen A, Chung B, et al
    Post-Heart Transplant Diabetes Mellitus: Incidence, Prevalence and Outcomes.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  266. D'ANGELO A, Naka Y, Sanchez J, Kaku Y, et al
    Outcomes of Mechanical Circulatory Support Therapy for Cardiogenic Shock Associated with Late Allograft Failure after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  267. ARAUJO-GUTIERREZ R, Bhimaraj A, Guha A, Hussain I, et al
    No Increase in Infections or Readmissions in Al Amyloid Patients Who Undergo Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  268. NYGAARD SI, Rolid K, Nytroen K, Fiane A, et al
    Heart Rate Response after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  269. ALI J, Mann S, Smith F, Rushton S, et al
    Recipient Age, Not Donor Age, Impacts on Long Term Outcomes Following Heart Transplantation: A 23-year National Analysis from the United Kingdom.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  270. ESMAILIAN F, Emerson D, Megna D, Ramzy D, et al
    Pre-Heart Transplant Glomerular Filtration Rate and Outcome.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  271. KHUSH K, Kao A, Eisen H, Hall S, et al
    Gene Expression Profile Scores by Allomap(R) are Higher in Heart Transplant Patients with Non-Skin Cancer Malignancy.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  272. JELENC M, Jelenc B, Vrtovec B, Knezevic I, et al
    Impact of Mechanical Circulatory Support and Heart Transplantation on Survival of the Population of Transplant Eligible Advanced Heart Failure Patients - A Computer Simulation Study.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  273. BOTTA L, Murana G, Fiorentino M, Marianna B, et al
    Impact of Severe Pulmonary Hypertension on Right Heart Hemodynamics and Outcomes Following Cardiac Transplantation: A Single Center Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  274. CHUN K, Lee C, Oh J, Park S, et al
    Increased Aortic Stiffness Index is Associated with Reduced Exercise Capacity Following Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  275. SONG W, Chen Q, Patel C, Yang Q, et al
    Pre-Formed Donor-Specific Antibodies Impact Long Term Survival of Heart Transplants.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  276. PATEL J, Kittleson M, Kransdorf E, Chang D, et al
    The Natural History of Pre-Existing Donor Specific Antibody and Amnestic Responses after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  277. GIBLIN G, Murphy L, Mahon N, Chughtai Z, et al
    Survival Trends Post Cardiac Transplantation: A Comparative Analysis of Irish and International Data (1985-2019).
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  278. JOCHER B, Nakajima T, Tanaka Y, Fischer I, et al
    Incidence and Risk Factors for Acute Kidney Injury Post-Heart Transplant: An Analysis of Peri-Operative Hemodynamics.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  279. ESMAILIAN F, Emerson D, Megna D, Ramzy D, et al
    The Outcome of Redo Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  280. RAVI Y, Zaver SM, Emani S, Lei D, et al
    Education and Its Impact on Post-Heart Transplant Survival.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  281. VEEN K, Papageorgiou G, Zijderhand C, Brugts J, et al
    The Clinical Impact and Long-Term Outcome of Tricuspid Regurgitation in Patients with Orthotopic Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  282. MUSLEM R, Yalcin YC, Yasar YE, Roest S, et al
    Impact of Left Ventricular Assist Device on Renal Function Following Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  283. EMMANUEL S, Pearman M, Jansz P, Hayward C, et al
    Vasopressor Requirement in Patients Undergoing Ventricular Assist Device Explant and Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  284. BENKE K, Ruppert M, Sayour AA, Jasz D, et al
    Methane-Enriched Custodiol Preservation Solution Improves Graft Function in Experimental Model of Heterotopic Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  285. LAMBERT AN, Weiner J, Hall M, Thurm C, et al
    Heart Transplant Outcomes in Children with Ebstein's Anomaly.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  286. JACKSON R, Heyrend C, Fullerton C, Benefield E, et al
    Safety and Efficacy of CD3 Guided Anti-Thymocyte Globulin Dosing after Pediatric Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  287. LAKS JA, Kiss A, Dipchand AI
    Immune Dysregulation after Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  288. HAYES EA, Hodge A, Meyer E, Nichol K, et al
    A Comparison of Intra-Operative Isohemagglutinin Removal Techniques in Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  289. MCGOVERN E, Hirsch R, Chin P, Morales DL, et al
    Quantitative Coronary Angiography Can Predict Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  290. MCGILL M, Evans M, Schmidt S, Griselli M, et al
    Relationship between Right Atrial Pressure and Inferior Vena Cava Dimensions in Pediatric Post Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  291. O'CONNOR MJ, Restaino K, Burstein DS, Rossano JW, et al
    Temporal Trends in Financing of Pediatric Heart Transplantation in the United States.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  292. AHMED H, Lee J, Profita E, Dykes J, et al
    Heightened Immune Response and Increased Risk of Infections in Pediatric Fontan Patients after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  293. FRANDSEN EL, Hingorani SR, Jorgensen N, Albers EL, et al
    Prevalence and Risk Factors of Proteinuria in Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  294. DUONG S, Hall M, Hollander SA, Thurm C, et al
    Impact of High- vs. Low-Frequency Surveillance Endomyocardial Biopsy Strategy in Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  295. JASSERON C, Audry B, Cantrelle C, Legeai C, et al
    Pediatric Heart Transplantation in France Since the Implementation of the New Allocation System.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  296. THANGAPPAN K, Haney L, Zafar F, Hossain M, et al
    What are the Expectations for Length of Stay after Pediatric Heart Transplantation?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  297. MOKSHAGUNDAM D, Castleberry CD, Simpson KE, Ybarra AM, et al
    Treatment and Pattern of Resolution of Antibody-Mediated Rejection with Hemodynamic Compromise Resistant to Standard Therapy after Heart Transplantation with a Positive Virtual Crossmatch.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  298. MAGNETTA DA, Thrush PT, Monge MC, Khan A, et al
    Insurance Type and Impact on Waitlist Mortality in Young Heart Transplant Candidates: A UNOS Registry Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  299. LUNZE FI, Singh TP, Harrild D, Gauvreau K, et al
    Three-Dimensional Speckle Tracking Echocardiography for Assessment of Left Ventricular Function and Myocardial Mechanics after Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  300. WEISERT MA, Harake D, Hede S, Russell M, et al
    A Multicenter Survey on Post-Transplant Lymphoproliferative Disorders in Pediatric Heart Transplant Recipients: A Case for Development of Consensus Guidelines for Screening, Surveillance and Treatment?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  301. SPINNER JA, Chen X, Denfield SW, Dreyer WJ, et al
    Intestinal Microbiome Composition Changes after Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  302. CHAU P, Fitts JA, Tan R, Bock MJ, et al
    Comparison of Sirolimus and Everolimus on Hematologic Parameters in Pediatric Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  303. FRANDSEN EL, Banker KA, Mazor RL, Law YM, et al
    When No VAD is the Right VAD: Medical Management of Critically Ill Infants Awaiting Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  304. CHEN S, Murray JM, Dykes J, Kaufman BD, et al
    Clinical Deterioration in Single Ventricle Infants Waiting for Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  305. TRAMMELL J, Epstein FR, Liu C, Dobbels F, et al
    Gender Differences in Adherence to Nonpharmacologic Recommendations after Heart Transplant: A Secondary Analysis from the International BRIGHT Study.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  306. KUMAI Y, Takeda K, Roth Z, Fried J, et al
    Residual Lung Injury Following HeartMate 3 Explantation for Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  307. SEGUCHI O, Youn J, Geft D, Cole R, et al
    The Burden of Total Artificial Heart Patients and Complications after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  308. PELED Y, Ram E, Kogan A, Rozenman J, et al
    Explantation of Left Ventricular Assist Device as Bridge Therapy is Associated with Diaphragm Dysfunction after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  309. FRANKEL WC, Godfrey EL, Suarez EE, Rana A, et al
    Data-Driven Volume Thresholds Predictive of Improved Outcomes after Orthotopic Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  310. FOLEY NM, Hardin M, Park B, Rahaman Z, et al
    Veteran Affairs Partnership Improves Access to High Volume, Quality Heart Transplant Programs. It Ain't Broke!
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  311. KREBS R, Kankainen M, Syrjala S, Nykanen A, et al
    Platelet Transcriptome as a Marker for Rejection after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  312. HOE LES, Wells MA, Bouquet M, Hyslop K, et al
    Metabolic and Mitochondrial Alterations Following Brain Death and Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  313. ALEKSOVA N, Billia F, Foroutan F, Buchan TA, et al
    Extracorporeal Membrane Oxygenation for Early Graft Dysfunction Following Heart Transplantation: A Systematic Review and Meta-Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  314. ZHU Y, Shudo Y, Lingala B, Elde S, et al
    The Impact of Donor Gender on Heart Transplantation Outcomes - A Study of over 60,000 Patients in the United States.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  315. YOUN J, Seguchi O, Cole R, Geft D, et al
    Desensitization in Mechanical Circulatory Support Patients Awaiting Heart Transplantation: What is the Post-Transplant Outcome?
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  316. DENG B, Kawabori M, Shindgikar P, Hironaka C, et al
    The Effect of Left Thoracotomy LVAD Implantation to LVAD Surgery and Followed Heart Transplantation Surgery.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  317. NISHIDA H, Jeevanandam V, Koda Y, Song T, et al
    Impact of Prophylactic Donor Heart Tricuspid Valve Annuloplasty in Long-Term Clinical Outcomes of Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  318. HUSSAIN Z, Yu MD, Wozniak A, Kim D, et al
    Impact of Donor Smoking History on Post Heart Transplant Outcomes: A Propensity Matched Analysis of the ISHLT Registry.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  319. PELED Y, Ram E, Klempfner R, Lavee J, et al
    Donor Thyroid Hormone Therapy and Heart Transplantation Outcomes: An Analysis of the ISHLT Registry Data.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  320. VIEIRA JL, Cherikh WS, Lindblad K, Stehlik J, et al
    Cocaine Use in Organ Donors and Long-Term Outcome after Heart Transplantation: An ISHLT Registry Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  321. ESMAILIAN FA, Emerson D, Megna D, Ramzy D, et al
    Heart Transplantation with Older Donors: Should There Be an Age Cutoff.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available

  322. HARLOFF M, Piechura L, Percy E, Hirji S, et al
    Safety of Mechanical Support via the Axillary Artery as a Bridge to Orthotopic Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed         Abstract available


    PLoS One

  323. JENNINGS DL, Bohn B, Zuver A, Onat D, et al
    Gut microbial diversity, inflammation, and oxidative stress are associated with tacrolimus dosing requirements early after heart transplantation.
    PLoS One. 2020;15:e0233646.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Heart Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: